HURA (TuHURA Biosciences) 1-Year Share Buyback Ratio: -40.20% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HURA TuHURA Biosciences Inc HURA
11 GF Score
Price $2.05
View Full Analysis

What is TuHURA Biosciences 1-Year Share Buyback Ratio?

TuHURA Biosciences HURA +0.99% 11 1-Year Share Buyback Ratio is -40.20 as of Jun. 2026. GuruFocus rates HURA with a GF Score™ of 11/100. Among 1,109 Biotechnology companies, TuHURA Biosciences ranks worse than 72.32% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. TuHURA Biosciences's current 1-Year Share Buyback Ratio was -40.20%.

HURA's 1-Year Share Buyback Ratio is ranked worse than
72.32% of 1109 companies
in the Biotechnology industry
Industry Median: -14.2 vs HURA: -40.20

TuHURA Biosciences  (NAS:HURA) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

TuHURA Biosciences 1-Year Share Buyback Ratio Related Terms

HURA vs INO, VTVT, CNTB: 1-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, TuHURA Biosciences's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences 1-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's 1-Year Share Buyback Ratio falls into.


HURA
11GF Score
TuHURA Biosciences Inc HURA
1-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences 1-Year Share Buyback Ratio Calculation

TuHURA Biosciences's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2025 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Jun. 2025 )
=(49.914 - 63.683) / 49.914
=-27.6%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -40.20 mean?
TuHURA Biosciences (HURA) has a 1-Year Share Buyback Ratio of -40.20 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for TuHURA Biosciences and its competitors. According to the industry distribution chart, TuHURA Biosciences ranks #802 out of 1109 companies in the Biotechnology industry, placing it in the top 72.3%.
Is TuHURA Biosciences' 1-Year Share Buyback Ratio too high?
TuHURA Biosciences' current 1-Year Share Buyback Ratio is -40.20. Based on the distribution chart, TuHURA Biosciences ranks #802 out of 1109 companies in the Biotechnology industry, which is below the industry midpoint. Overall, TuHURA Biosciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' 1-Year Share Buyback Ratio compare to INO and VTVT?
According to the Biotechnology industry distribution chart, TuHURA Biosciences ranks #802 out of 1109 companies for 1-Year Share Buyback Ratio. This places TuHURA Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Biotechnology company?
A good 1-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for TuHURA Biosciences and its competitors. TuHURA Biosciences's current 1-Year Share Buyback Ratio is -40.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current 1-Year Share Buyback Ratio of -40.20. The current 1-Year Share Buyback Ratio is -40.20. TuHURA Biosciences' overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current 1-Year Share Buyback Ratio is -40.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
11GF Score

Get the complete analysis for HURA

1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.05
Price